Respiratory Syncytial Virus Infections

• CLINICAL_TRIALS trial_result · 2023-04-07
  Clinical Trial Update: A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age [Phase 3]

  Phase 3 trial evaluating safety and immune response of an unadjuvanted RSV maternal vaccine in healthy non-pregnant females aged 9-49; study…

• CLINICAL_TRIALS trial_result · 2022-10-26
  Clinical Trial Update: Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection. [Phase 2]

  Phase 2 trial evaluating antiviral activity, safety, and pharmacokinetics of repeated doses of JNJ 53718678 for respiratory syncytial virus …

• CLINICAL_TRIALS trial_result · 2022-10-18
  Clinical Trial Update: A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above [Phase 3]

  Phase 3 trial evaluating the immune response and safety of an RSV vaccine given alone and with an influenza vaccine in adults aged 60 years …

• CLINICAL_TRIALS trial_result · 2022-07-27
  Clinical Trial Update: Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV [Phase 1, Phase 2]

  Phase 1/2 clinical trial update for an RSV investigational vaccine in infants 6–7 months old completed; results posted in 2022.

• CLINICAL_TRIALS trial_result · 2022-06-28
  Clinical Trial Update: A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus [Phase 2]

  This Phase 2 trial assessed the antiviral activity, clinical outcomes, safety, tolerability, and pharmacokinetics of JNJ-53718678 in non-hos…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-05-27
  Clinical Trial Update: RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women. [Phase 2]

  Phase 2 clinical trial update for a maternal immunization RSV F vaccine in healthy third-trimester pregnant women (completed).

• CLINICAL_TRIALS trial_result · 2021-12-13
  Clinical Trial Update: Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants [Phase 2]

  Phase 2 trial assessing safety, reactogenicity, and immunogenicity of GSK's maternal unadjuvanted RSV vaccine in healthy pregnant women and …

• CLINICAL_TRIALS trial_result · 2021-10-28
  Clinical Trial Update: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants [Phase 1, Phase 2]

  Clinical trial update for GSK's RSV vaccine based on chimpanzee adenovector (ChAd155-RSV) in RSV-seropositive infants; Phase 1/Phase 2 compl…

• CLINICAL_TRIALS trial_result · 2021-04-13
  Clinical Trial Update: A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus Infection [Phase 2]

  A Phase 2 long-term follow-up study assessing whether lumicitabine affects the incidence of asthma and/or wheezing in infants and children a…

• CLINICAL_TRIALS trial_result · 2021-02-15
  Clinical Trial Update: Respiratory Syncytial Virus - RSV Protocol [Phase 2]

  Phase 2 RSV protocol trial completed; results posted in 2021 for a study sponsored by MD Anderson Cancer Center investigating respiratory sy…

• CLINICAL_TRIALS trial_result · 2020-12-11
  Clinical Trial Update: A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV [Phase 1]

  Phase 1 trial assessing safety, tolerability, and immunogenicity of the live attenuated hRSV vaccine rBCG-N-hRSV; study completed with resul…

• CLINICAL_TRIALS trial_result · 2020-09-22
  Clinical Trial Update: RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults [Phase 2]

  Phase II trial update for the RSV-MVA-BN vaccine in adults aged 55 and older; trial completed with results posted in 2020.

• CLINICAL_TRIALS trial_result · 2019-11-27
  Clinical Trial Update: Anti-RSV Study in Chinese Patients (ASCENT) [Phase 2]

  Phase 2 clinical trial update for an anti-RSV study conducted in Chinese patients (ASCENT) with unknown status.

• CLINICAL_TRIALS trial_result · 2019-10-14
  Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants. [Phase 2]

  Phase 2 trial evaluating the safety and efficacy of MEDI8897 to prevent medically attended RSV lower respiratory tract infection in healthy …

• CLINICAL_TRIALS trial_result · 2019-06-14
  Clinical Trial Update: Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age [Phase 1]

  Phase 1 clinical trial evaluating a recombinant live-attenuated RSV vaccine in seronegative infants to assess infectivity, safety, and immun…

• CLINICAL_TRIALS trial_result · 2018-11-20
  Clinical Trial Update: A Study to Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women [Phase 2]

  Phase 2 trial evaluating different doses of GSK's RSV vaccine (GSK3003891A) in healthy adult women to assess immune response and safety; stu…

• CLINICAL_TRIALS trial_result · 2018-08-20
  Clinical Trial Update: A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults [Phase 1]

  Phase 1 trial assessing safety and immunogenicity of GSK's RSV vaccine ChAd155-RSV (GSK3389245A) in healthy adults completed with results po…

• CLINICAL_TRIALS trial_result · 2018-07-02
  Clinical Trial Update: A Study of AK0529 in Infants Hospitalized With RSV [Phase 1]

  A Phase 1 trial of the RSV therapy AK0529 in infants hospitalized with Respiratory Syncytial Virus infections was terminated.

• CLINICAL_TRIALS trial_result · 2018-05-16
  Clinical Trial Update: A Study of PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study [Phase 1, Phase 2]

  Completed Phase 1/2 study evaluating antiviral activity, safety, and pharmacokinetics of multiple doses of PC786 in an RSV challenge model.

• CLINICAL_TRIALS trial_result · 2018-02-05
  Clinical Trial Update: Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) [Phase 2]

  Phase 2b trial update for ALN-RSV01 in lung transplant patients with RSV infection has been completed.

• CLINICAL_TRIALS trial_result · 2018-01-29
  Clinical Trial Update: Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) [Phase 2]

  Phase 2 study update for ALN-RSV01 in lung transplant patients with RSV infection completed.

• CLINICAL_TRIALS trial_result · 2016-11-28
  Clinical Trial Update: A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults [Phase 1]

  This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of MEDI8897 in healthy adults to support further development for…

• CLINICAL_TRIALS trial_result · 2016-08-10
  Clinical Trial Update: Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine [Phase 1]

  A Phase 1 trial evaluating the safety, tolerability and immunogenicity of Bavarian Nordic's Recombinant MVA BN RSV Vaccine has completed.

• CLINICAL_TRIALS trial_result · 2016-07-11
  Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Participants [Phase 1]

  Phase 1 study evaluating safety, tolerability, and pharmacokinetics of ALS-008176 in healthy Japanese adults for respiratory syncytial virus…

• CLINICAL_TRIALS trial_result · 2016-06-01
  Clinical Trial Update: Assessment of Airway Obstruction in Infants With Lower Respiratory Infections [NA]

  ClinicalTrials.gov update notes the trial assessing airway obstruction in infants with bronchiolitis and RSV infections has completed. Resul…